[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,634,485
  • Shares Outstanding, K 193,284
  • Annual Sales, $ 3,221 M
  • Annual Income, $ 348,900 K
  • EBIT $ 334 M
  • EBITDA $ 409 M
  • 60-Month Beta 0.25
  • Price/Sales 3.31
  • Price/Cash Flow 19.32
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 34.90% (-7.74%)
  • Historical Volatility 43.86%
  • IV Percentile 20%
  • IV Rank 26.45%
  • IV High 55.46% on 02/23/26
  • IV Low 27.50% on 01/15/26
  • Expected Move (DTE 29) 3.55 (6.48%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 179
  • Volume Avg (30-Day) 1,098
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 37,913
  • Open Int (30-Day) 34,658
  • Expected Range 51.32 to 58.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.79
  • Number of Estimates 6
  • High Estimate $0.99
  • Low Estimate $0.62
  • Prior Year $1.25
  • Growth Rate Est. (year over year) -36.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.41 +11.01%
on 05/20/26
58.26 -5.85%
on 06/10/26
+5.18 (+10.43%)
since 05/18/26
3-Month
49.26 +11.35%
on 05/18/26
58.26 -5.85%
on 06/10/26
-0.58 (-1.05%)
since 03/18/26
52-Week
49.26 +11.35%
on 05/18/26
66.28 -17.24%
on 02/24/26
-0.39 (-0.71%)
since 06/18/25

Most Recent Stories

More News
BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026

Data from an investigator-led study showed treatment with VOXZOGO resulted in sustained improvements in growth over three years in children with hypochondroplasia

BMRN : 54.87 (-0.27%)
2 Profitable Stocks Worth Your Attention and 1 We Find Risky

2 Profitable Stocks Worth Your Attention and 1 We Find Risky

PTLO : 4.34 (+2.84%)
BMRN : 54.87 (-0.27%)
ACN : 128.67 (-17.52%)
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

BMRN : 54.87 (-0.27%)
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

LMND : 57.84 (+0.98%)
BMRN : 54.87 (-0.27%)
AVO : 11.52 (+4.07%)
BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

Study met primary endpoint, exceeding expectations with a highly statistically significant improvement in annualized growth velocity (AGV, change from baseline) of 2.33 cm/yr compared to placebo at week...

BMRN : 54.87 (-0.27%)
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

ENERGY 3 study met 1 of 2 co-primary endpoints in children with ENPP1 deficiency

BMRN : 54.87 (-0.27%)
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

SEZL : 158.72 (+8.17%)
BMRN : 54.87 (-0.27%)
USFD : 94.27 (+0.55%)
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

BMRN : 54.87 (-0.27%)
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN : 54.87 (-0.27%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 54.87 (-0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 57.46
2nd Resistance Point 56.76
1st Resistance Point 55.89
Last Price 54.87
1st Support Level 54.32
2nd Support Level 53.62
3rd Support Level 52.75

See More

52-Week High 66.28
Fibonacci 61.8% 59.77
Fibonacci 50% 57.77
Fibonacci 38.2% 55.76
Last Price 54.87
52-Week Low 49.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.